Angeline Bartholomeusz

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

Peter Angus, Rhys Vaughan, Shelly Xiong et al. · Gastroenterology · 2003 · 567 citations

Novel Mutation, Molecular Virology, Pathogenesis +7

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2004 · 537 citations · Full text

Vaccination, Clinical Emergence, Health Sciences +15

Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir

Julie Sheldon, Nuria Camino, Berta Rodés et al. · Antiviral Therapy · 2005 · 288 citations · Full text

Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation

George Lau, Ming‐Liang He, Angeline Bartholomeusz et al. · Hepatology · 2002 · 193 citations

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

Gail Matthews, Angeline Bartholomeusz, Stephen Locarnini et al. · AIDS · 2006 · 181 citations